NY Antitrust Suit Tests Key Tactic Of Brand-Name Drugmakers
New York's lawsuit this week accusing Actavis PLC and Forest Laboratories LLC of discontinuing a popular dementia drug's original version in order to switch patients to a newer version with extended...To view the full article, register now.
Already a subscriber? Click here to view full article